Lilium N.V., the German electric vertical takeoff and landing (eVTOL) aircraft developer, has seen its stock plunge to micro-penny levels, trading around $0.0001 per share on over-the-counter (OTC) markets. The dramatic decline follows a Nasdaq delisting in March 2025 and a reported patent sale in October 2025, leaving the company's future in question.
What Happened to Lilium?
Lilium was once a high-flying SPAC merger story, promising to revolutionize regional air mobility with its all-electric Lilium Jet. The company's business model was built on two pillars: designing, certifying, and producing the aircraft, and then operating the ecosystem around it—including vertiports, maintenance, and flight operations. Revenue was expected to come from aircraft sales, service contracts, and network fees.
In practice, Lilium remained a pre-revenue company, burning through cash on research and development. The capital-intensive nature of aircraft certification and production proved challenging, especially as interest rates rose and investor appetite for speculative growth stories waned.
The company's troubles came to a head in early 2025 when Nasdaq delisted its shares after the stock failed to maintain the exchange's minimum bid price requirements. Trading then moved to the OTC markets, where liquidity is thinner and investor visibility is lower. The reported patent sale in October 2025—while not officially confirmed by the company in filings—suggests Lilium is selling off intellectual property to raise cash.
What This Means for Investors
For everyday investors, Lilium's slide to $0.0001 is a stark reminder of the risks in pre-revenue, capital-intensive startups. Even promising technologies can fail to reach commercialization if funding dries up or execution falters. The OTC market is less regulated and less liquid than major exchanges like Nasdaq, making it harder to buy or sell shares without significant price swings.
Investors who bought Lilium during its SPAC heyday have seen their holdings lose nearly all value. The stock's current price of $0.0001 means a $1,000 investment would now be worth just $0.10—a 99.99% loss. This highlights the importance of diversification and understanding that early-stage companies often face existential risks.
For context, other struggling eVTOL companies have faced similar fates. The sector, once hyped as the future of urban transportation, has struggled with regulatory hurdles, high costs, and a lack of proven demand. Lilium's patent sale may provide a short-term cash infusion, but it also raises questions about the company's ability to protect its core technology and compete in the long run.
Broader Market Context
The broader market has seen a shift away from speculative growth stocks in recent years, as rising interest rates made safer assets more attractive. While AI optimism drove the S&P 500 to a 1.2% weekly gain recently, that enthusiasm has not extended to cash-burning startups like Lilium. The company's struggles also contrast with more established firms that have successfully navigated market challenges, such as Mueller Industries, which recently announced a stock split alongside record earnings and a dividend hike.
Meanwhile, some companies are finding new life through IPOs, like Tailored Brands, which filed for a Nasdaq IPO as it seeks to shed its bankruptcy past. Lilium's path, however, appears to be heading in the opposite direction.
What to Watch Next
Investors should monitor Lilium's next financial filings for details on the patent sale and any restructuring plans. The company may need to raise additional capital through equity offerings, which would further dilute existing shareholders. Alternatively, a sale of the entire company or a merger could provide an exit for investors, though at current valuations, any recovery would likely be minimal.
For those holding Lilium shares, the key question is whether the company can secure enough funding to reach certification and production. Without a clear path to revenue, the stock's micro-penny status may persist or worsen. As always, investors should consider their own risk tolerance and avoid putting money they cannot afford to lose into speculative positions.
